52 related articles for article (PubMed ID: 9563848)
21. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells.
Xu L; Gonzalez-Agosti C; Beauchamp R; Pinney D; Sterner C; Ramesh V
Exp Cell Res; 1998 Jan; 238(1):231-40. PubMed ID: 9457076
[TBL] [Abstract][Full Text] [Related]
22. Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixin.
Bono P; Cordero E; Johnson K; Borowsky M; Ramesh V; Jacks T; Hynes RO
Exp Cell Res; 2005 Aug; 308(1):177-87. PubMed ID: 15913605
[TBL] [Abstract][Full Text] [Related]
23. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
[TBL] [Abstract][Full Text] [Related]
24. The merlin tumor suppressor localizes preferentially in membrane ruffles.
Gonzalez-Agosti C; Xu L; Pinney D; Beauchamp R; Hobbs W; Gusella J; Ramesh V
Oncogene; 1996 Sep; 13(6):1239-47. PubMed ID: 8808698
[TBL] [Abstract][Full Text] [Related]
25. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
Schmucker B; Ballhausen WG; Kressel M
Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
[TBL] [Abstract][Full Text] [Related]
26. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
27. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
28. NF2: the wizardry of merlin.
Xiao GH; Chernoff J; Testa JR
Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
[TBL] [Abstract][Full Text] [Related]
29. The tumour suppressor protein NF2/merlin: the puzzle continues.
Hovens CM; Kaye AH
J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
[TBL] [Abstract][Full Text] [Related]
30. Shedding light on Merlin's wizardry.
Okada T; You L; Giancotti FG
Trends Cell Biol; 2007 May; 17(5):222-9. PubMed ID: 17442573
[TBL] [Abstract][Full Text] [Related]
31. Radixin: cytoskeletal adopter and signaling protein.
Hoeflich KP; Ikura M
Int J Biochem Cell Biol; 2004 Nov; 36(11):2131-6. PubMed ID: 15313460
[TBL] [Abstract][Full Text] [Related]
32. [Molecular biological analysis of neurofibromatosis type 2 gene].
Ichimura K; Yuasa Y
Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
[TBL] [Abstract][Full Text] [Related]
33. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling.
Gautreau A; Louvard D; Arpin M
Curr Opin Cell Biol; 2002 Feb; 14(1):104-9. PubMed ID: 11792551
[TBL] [Abstract][Full Text] [Related]
34. The merlin interacting proteins reveal multiple targets for NF2 therapy.
Scoles DR
Biochim Biophys Acta; 2008 Jan; 1785(1):32-54. PubMed ID: 17980164
[TBL] [Abstract][Full Text] [Related]
35. Schwannomin: new insights into this member of the band 4.1 superfamily.
Belliveau MJ; Lutchman M; Claudio JO; Marineau C; Rouleau GA
Biochem Cell Biol; 1995; 73(9-10):733-7. PubMed ID: 8714694
[TBL] [Abstract][Full Text] [Related]
36. Structure-function relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein.
Turunen O; Sainio M; Jääskeläinen J; Carpén O; Vaheri A
Biochim Biophys Acta; 1998 Sep; 1387(1-2):1-16. PubMed ID: 9748471
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
